Clinical Trials
2 trialsNCT04981509 2026-06-03
Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer
National Cancer Institute (NCI)
Phase 2 Recruiting
NCT00726323 2017-12-11
A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)
GlaxoSmithKline
Phase 2 Completed